Report Detail
Global and United States Orthopedic Regenerative Medicine Market Report & Forecast 2022-2028
- RnM4448032 |
- 31 May, 2022 |
- Global |
- 114 Pages |
- QYResearch |
- Service & Software
Summary:
Market Analysis and Insights: Global and United States Orthopedic Regenerative Medicine Market
This report focuses on global and United States Orthopedic Regenerative Medicine market, also covers the segmentation data of other regions in regional level and county level.
Due to the COVID-19 pandemic, the global Orthopedic Regenerative Medicine market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Type, Stem Cell Therapy (Allogeneic Bones, Autogeneic Bones, and Bone Grafting) accounting for % of the Orthopedic Regenerative Medicine global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, Osteoarticular Diseases was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.
In United States the Orthopedic Regenerative Medicine market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
Global Orthopedic Regenerative Medicine Scope and Market Size
Orthopedic Regenerative Medicine market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Orthopedic Regenerative Medicine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Orthopedic Regenerative Medicine market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type, the Orthopedic Regenerative Medicine market is segmented into
Stem Cell Therapy (Allogeneic Bones, Autogeneic Bones, and Bone Grafting)
Plasma Based Therapy
Tissue Engineering (Allograft)
Segment by Application, the Orthopedic Regenerative Medicine market is segmented into
Osteoarticular Diseases
Rheumatoid Arthritis
Ligament Injuries
Bursitis
Osteoporosis
Regional and Country-level Analysis
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Competitive Landscape and Orthopedic Regenerative Medicine Market Share Analysis
Orthopedic Regenerative Medicine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2017-2022. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2017-2022. Details included are company description, major business, company total revenue and the sales, revenue generated in Orthopedic Regenerative Medicine business, the date to enter into the Orthopedic Regenerative Medicine market, Revenue in Orthopedic Regenerative Medicine Business (2017-2022) & (US$ Million) introduction, recent developments, etc.
The major vendors covered:
Ortho Regenerative Technologies Inc
Personalized stem cells Inc.
Anika Therapeutics Inc.
Arthrex Inc.
Baxter International Inc.
Conmed Corporation
Aziyo Biologics
Curasan Inc.
Swiss biomed Orthopedics AG
Octane Medical Inc.
Stryker Corporation
Carmell Therapeutics Corporation
Zimmer Holdings
Smith & Nephew plc.
NuVasive Inc.
Table of Contents
1 Study Coverage
- 1.1 Orthopedic Regenerative Medicine Revenue in Orthopedic Regenerative Medicine Business (2017-2022) & (US$ Million) Introduction
- 1.2 Global Orthopedic Regenerative Medicine Outlook 2017 VS 2022 VS 2028
- 1.2.1 Global Orthopedic Regenerative Medicine Market Size for the Year 2017-2028
- 1.2.2 Global Orthopedic Regenerative Medicine Market Size for the Year 2017-2028
- 1.3 Orthopedic Regenerative Medicine Market Size, United States VS Global, 2017 VS 2022 VS 2028
- 1.3.1 The Market Share of United States Orthopedic Regenerative Medicine in Global, 2017 VS 2022 VS 2028
- 1.3.2 The Growth Rate of Orthopedic Regenerative Medicine Market Size, United States VS Global, 2017 VS 2022 VS 2028
- 1.4 Orthopedic Regenerative Medicine Market Dynamics
- 1.4.1 Orthopedic Regenerative Medicine Industry Trends
- 1.4.2 Orthopedic Regenerative Medicine Market Drivers
- 1.4.3 Orthopedic Regenerative Medicine Market Challenges
- 1.4.4 Orthopedic Regenerative Medicine Market Restraints
- 1.5 Study Objectives
- 1.6 Years Considered
2 Orthopedic Regenerative Medicine by Type
- 2.1 Orthopedic Regenerative Medicine Market Segment by Type
- 2.1.1 Stem Cell Therapy (Allogeneic Bones, Autogeneic Bones, and Bone Grafting)
- 2.1.2 Plasma Based Therapy
- 2.1.3 Tissue Engineering (Allograft)
- 2.2 Global Orthopedic Regenerative Medicine Market Size by Type (2017, 2022 & 2028)
- 2.3 Global Orthopedic Regenerative Medicine Market Size by Type (2017-2028)
- 2.4 United States Orthopedic Regenerative Medicine Market Size by Type (2017, 2022 & 2028)
- 2.5 United States Orthopedic Regenerative Medicine Market Size by Type (2017-2028)
3 Orthopedic Regenerative Medicine by Application
- 3.1 Orthopedic Regenerative Medicine Market Segment by Application
- 3.1.1 Osteoarticular Diseases
- 3.1.2 Rheumatoid Arthritis
- 3.1.3 Ligament Injuries
- 3.1.4 Bursitis
- 3.1.5 Osteoporosis
- 3.2 Global Orthopedic Regenerative Medicine Market Size by Application (2017, 2022 & 2028)
- 3.3 Global Orthopedic Regenerative Medicine Market Size by Application (2017-2028)
- 3.4 United States Orthopedic Regenerative Medicine Market Size by Application (2017, 2022 & 2028)
- 3.5 United States Orthopedic Regenerative Medicine Market Size by Application (2017-2028)
4 Global Orthopedic Regenerative Medicine Competitor Landscape by Company
- 4.1 Global Orthopedic Regenerative Medicine Market Size by Company
- 4.1.1 Top Global Orthopedic Regenerative Medicine Companies Ranked by Revenue (2021)
- 4.1.2 Global Orthopedic Regenerative Medicine Revenue by Player (2017-2022)
- 4.2 Global Orthopedic Regenerative Medicine Concentration Ratio (CR)
- 4.2.1 Orthopedic Regenerative Medicine Market Concentration Ratio (CR) (2017-2022)
- 4.2.2 Global Top 5 and Top 10 Largest Companies of Orthopedic Regenerative Medicine in 2021
- 4.2.3 Global Orthopedic Regenerative Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 4.3 Global Orthopedic Regenerative Medicine Headquarters, Revenue in Orthopedic Regenerative Medicine Business (2017-2022) & (US$ Million) Type
- 4.3.1 Global Orthopedic Regenerative Medicine Headquarters and Area Served
- 4.3.2 Global Orthopedic Regenerative Medicine Companies Revenue in Orthopedic Regenerative Medicine Business (2017-2022) & (US$ Million) Type
- 4.3.3 Date of International Companies Enter into Orthopedic Regenerative Medicine Market
- 4.4 Companies Mergers & Acquisitions, Expansion Plans
- 4.5 United States Orthopedic Regenerative Medicine Market Size by Company
- 4.5.1 Top Orthopedic Regenerative Medicine Players in United States, Ranked by Revenue (2021)
- 4.5.2 United States Orthopedic Regenerative Medicine Revenue by Players (2020, 2021 & 2022)
5 Global Orthopedic Regenerative Medicine Market Size by Region
- 5.1 Global Orthopedic Regenerative Medicine Market Size by Region: 2017 VS 2022 VS 2028
- 5.2 Global Orthopedic Regenerative Medicine Market Size by Region (2017-2028)
- 5.2.1 Global Orthopedic Regenerative Medicine Market Size by Region: 2017-2022
- 5.2.2 Global Orthopedic Regenerative Medicine Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
- 6.1 North America
- 6.1.1 North America Orthopedic Regenerative Medicine Market Size YoY Growth 2017-2028
- 6.1.2 North America Orthopedic Regenerative Medicine Market Facts & Figures by Country (2017, 2022 & 2028)
- 6.1.3 United States
- 6.1.4 Canada
- 6.2 Asia-Pacific
- 6.2.1 Asia-Pacific Orthopedic Regenerative Medicine Market Size YoY Growth 2017-2028
- 6.2.2 Asia-Pacific Orthopedic Regenerative Medicine Market Facts & Figures by Region (2017, 2022 & 2028)
- 6.2.3 China
- 6.2.4 Japan
- 6.2.5 South Korea
- 6.2.6 India
- 6.2.7 Australia
- 6.2.8 China Taiwan
- 6.2.9 Indonesia
- 6.2.10 Thailand
- 6.2.11 Malaysia
- 6.3 Europe
- 6.3.1 Europe Orthopedic Regenerative Medicine Market Size YoY Growth 2017-2028
- 6.3.2 Europe Orthopedic Regenerative Medicine Market Facts & Figures by Country (2017, 2022 & 2028)
- 6.3.3 Germany
- 6.3.4 France
- 6.3.5 U.K.
- 6.3.6 Italy
- 6.3.7 Russia
- 6.4 Latin America
- 6.4.1 Latin America Orthopedic Regenerative Medicine Market Size YoY Growth 2017-2028
- 6.4.2 Latin America Orthopedic Regenerative Medicine Market Facts & Figures by Country (2017, 2022 & 2028)
- 6.4.3 Mexico
- 6.4.4 Brazil
- 6.4.5 Argentina
- 6.4.6 Colombia
- 6.5 Middle East and Africa
- 6.5.1 Middle East and Africa Orthopedic Regenerative Medicine Market Size YoY Growth 2017-2028
- 6.5.2 Middle East and Africa Orthopedic Regenerative Medicine Market Facts & Figures by Country (2017, 2022 & 2028)
- 6.5.3 Turkey
- 6.5.4 Saudi Arabia
- 6.5.5 UAE
7 Company Profiles
- 7.1 Ortho Regenerative Technologies Inc
- 7.1.1 Ortho Regenerative Technologies Inc Company Details
- 7.1.2 Ortho Regenerative Technologies Inc Business Overview
- 7.1.3 Ortho Regenerative Technologies Inc Orthopedic Regenerative Medicine Introduction
- 7.1.4 Ortho Regenerative Technologies Inc Revenue in Orthopedic Regenerative Medicine Business (2017-2022)
- 7.1.5 Ortho Regenerative Technologies Inc Recent Development
- 7.2 Personalized stem cells Inc.
- 7.2.1 Personalized stem cells Inc. Company Details
- 7.2.2 Personalized stem cells Inc. Business Overview
- 7.2.3 Personalized stem cells Inc. Orthopedic Regenerative Medicine Introduction
- 7.2.4 Personalized stem cells Inc. Revenue in Orthopedic Regenerative Medicine Business (2017-2022)
- 7.2.5 Personalized stem cells Inc. Recent Development
- 7.3 Anika Therapeutics Inc.
- 7.3.1 Anika Therapeutics Inc. Company Details
- 7.3.2 Anika Therapeutics Inc. Business Overview
- 7.3.3 Anika Therapeutics Inc. Orthopedic Regenerative Medicine Introduction
- 7.3.4 Anika Therapeutics Inc. Revenue in Orthopedic Regenerative Medicine Business (2017-2022)
- 7.3.5 Anika Therapeutics Inc. Recent Development
- 7.4 Arthrex Inc.
- 7.4.1 Arthrex Inc. Company Details
- 7.4.2 Arthrex Inc. Business Overview
- 7.4.3 Arthrex Inc. Orthopedic Regenerative Medicine Introduction
- 7.4.4 Arthrex Inc. Revenue in Orthopedic Regenerative Medicine Business (2017-2022)
- 7.4.5 Arthrex Inc. Recent Development
- 7.5 Baxter International Inc.
- 7.5.1 Baxter International Inc. Company Details
- 7.5.2 Baxter International Inc. Business Overview
- 7.5.3 Baxter International Inc. Orthopedic Regenerative Medicine Introduction
- 7.5.4 Baxter International Inc. Revenue in Orthopedic Regenerative Medicine Business (2017-2022)
- 7.5.5 Baxter International Inc. Recent Development
- 7.6 Conmed Corporation
- 7.6.1 Conmed Corporation Company Details
- 7.6.2 Conmed Corporation Business Overview
- 7.6.3 Conmed Corporation Orthopedic Regenerative Medicine Introduction
- 7.6.4 Conmed Corporation Revenue in Orthopedic Regenerative Medicine Business (2017-2022)
- 7.6.5 Conmed Corporation Recent Development
- 7.7 Aziyo Biologics
- 7.7.1 Aziyo Biologics Company Details
- 7.7.2 Aziyo Biologics Business Overview
- 7.7.3 Aziyo Biologics Orthopedic Regenerative Medicine Introduction
- 7.7.4 Aziyo Biologics Revenue in Orthopedic Regenerative Medicine Business (2017-2022)
- 7.7.5 Aziyo Biologics Recent Development
- 7.8 Curasan Inc.
- 7.8.1 Curasan Inc. Company Details
- 7.8.2 Curasan Inc. Business Overview
- 7.8.3 Curasan Inc. Orthopedic Regenerative Medicine Introduction
- 7.8.4 Curasan Inc. Revenue in Orthopedic Regenerative Medicine Business (2017-2022)
- 7.8.5 Curasan Inc. Recent Development
- 7.9 Swiss biomed Orthopedics AG
- 7.9.1 Swiss biomed Orthopedics AG Company Details
- 7.9.2 Swiss biomed Orthopedics AG Business Overview
- 7.9.3 Swiss biomed Orthopedics AG Orthopedic Regenerative Medicine Introduction
- 7.9.4 Swiss biomed Orthopedics AG Revenue in Orthopedic Regenerative Medicine Business (2017-2022)
- 7.9.5 Swiss biomed Orthopedics AG Recent Development
- 7.10 Octane Medical Inc.
- 7.10.1 Octane Medical Inc. Company Details
- 7.10.2 Octane Medical Inc. Business Overview
- 7.10.3 Octane Medical Inc. Orthopedic Regenerative Medicine Introduction
- 7.10.4 Octane Medical Inc. Revenue in Orthopedic Regenerative Medicine Business (2017-2022)
- 7.10.5 Octane Medical Inc. Recent Development
- 7.11 Stryker Corporation
- 7.11.1 Stryker Corporation Company Details
- 7.11.2 Stryker Corporation Business Overview
- 7.11.3 Stryker Corporation Orthopedic Regenerative Medicine Introduction
- 7.11.4 Stryker Corporation Revenue in Orthopedic Regenerative Medicine Business (2017-2022)
- 7.11.5 Stryker Corporation Recent Development
- 7.12 Carmell Therapeutics Corporation
- 7.12.1 Carmell Therapeutics Corporation Company Details
- 7.12.2 Carmell Therapeutics Corporation Business Overview
- 7.12.3 Carmell Therapeutics Corporation Orthopedic Regenerative Medicine Introduction
- 7.12.4 Carmell Therapeutics Corporation Revenue in Orthopedic Regenerative Medicine Business (2017-2022)
- 7.12.5 Carmell Therapeutics Corporation Recent Development
- 7.13 Zimmer Holdings
- 7.13.1 Zimmer Holdings Company Details
- 7.13.2 Zimmer Holdings Business Overview
- 7.13.3 Zimmer Holdings Orthopedic Regenerative Medicine Introduction
- 7.13.4 Zimmer Holdings Revenue in Orthopedic Regenerative Medicine Business (2017-2022)
- 7.13.5 Zimmer Holdings Recent Development
- 7.14 Smith & Nephew plc.
- 7.14.1 Smith & Nephew plc. Company Details
- 7.14.2 Smith & Nephew plc. Business Overview
- 7.14.3 Smith & Nephew plc. Orthopedic Regenerative Medicine Introduction
- 7.14.4 Smith & Nephew plc. Revenue in Orthopedic Regenerative Medicine Business (2017-2022)
- 7.14.5 Smith & Nephew plc. Recent Development
- 7.15 NuVasive Inc.
- 7.15.1 NuVasive Inc. Company Details
- 7.15.2 NuVasive Inc. Business Overview
- 7.15.3 NuVasive Inc. Orthopedic Regenerative Medicine Introduction
- 7.15.4 NuVasive Inc. Revenue in Orthopedic Regenerative Medicine Business (2017-2022)
- 7.15.5 NuVasive Inc. Recent Development
8 Research Findings and Conclusion
9 Appendix
- 9.1 Research Methodology
- 9.1.1 Methodology/Research Approach
- 9.1.2 Data Source
- 9.2 Author Details
Summary:
Get latest Market Research Reports on Orthopedic Regenerative Medicine. Industry analysis & Market Report on Orthopedic Regenerative Medicine is a syndicated market report, published as Global and United States Orthopedic Regenerative Medicine Market Report & Forecast 2022-2028. It is complete Research Study and Industry Analysis of Orthopedic Regenerative Medicine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
